Skip to content

Tumor-specific diagnosis of F-18 FBPA PET / CT

Reserch for threshold SUV to differentiate malignant tumors and inflammation with F-18 FBPA PET / CT

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs051190116
Enrollment
100
Registered
2020-03-04
Start date
2020-03-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with lesions that are difficult to distinguish between tumor and inflammation tumor, inflammation

Interventions

Patients receive from intravenous injection of 18F-FBPA and blood collection, as well as radiation exposure from PET-CT scan.
blood collection, intravenous injection of 18F-FBPA, and radiation exposure from PET-CT scan

Sponsors

Ono Koji
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with lesions that are difficult to distinguish between tumor and inflammation

Exclusion criteria

Exclusion criteria: Pregnant women or those who wish to become pregnant Under 20 years of age A person who is determined to be unsuitable for participation in this study by the researcher or researcher

Design outcomes

Primary

MeasureTime frame
SUV value (SUV max, SUV mean) of target lesions obtained with F-18 FBPA PET / CT Pathological diagnosis (benign/ malignant judgment)

Secondary

MeasureTime frame
Radioactivity ratio between the target lesion and the left ventricular blood pool obtained with F-18 FBPA PET / CT (Lesion / Blood ratio) Radioactivity ratio (Lesion / Normal ratio) between target lesions and contralateral normal tissues obtained with F-18 FBPA PET / CT Radioactivity ratio between blood radioactivity and blood pool in the left ventricular calculated from F-18 FBPA PET / CT images The above items are evaluated and analyzed for each patient.

Contacts

Public ContactKayako Isohashi

Osaka Medical and Pharmaceutical University, Kansai BNCT Medical Center

kayako.isohashi@ompu.ac.jp+81-72-684-7116

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026